Abstract
ABSTRACT: We report the case of a boy who developed a motor neuropathy during infectious episodes at 18 mo and 3 y of age. When he was 7 y old, he suffered persistent weakness and areflexia; his resting lactate and pyruvate values were 3.65 mM and 398 μM, respectively (controls: 1.1 ± 0.3 mM and 90 ± 22 μM), and an exercise test demonstrated a lactic acidosis (13.6 mM; controls: 6.4 ± 1.3 mM) with a high pyruvate level (537 μM; controls: 176 ± 15 μM) and a low lactate/pyruvate ratio (24.2; controls: 35 ± 2). The results of polarographic studies on muscle mitochondria suggested a defect in pyruvate oxidation (pyruvate 17 ng atom O/min/mg protein; controls: 115 ± 42), whereas glutamate, palmitoylcarnitine, and succinate were good respiratory substrates. The activity of total pyruvate dehydrogenase complex (PDHC) in muscle mitochondria and in fresh mononuclear cells was markedly decreased (9.7 and 0.054 nmol 14CO2/min/mg protein, respectively; controls: 123 ± 4.5 and 0.733 ± 0.03, respectively). Immunochemical analysis in muscle mitochondria demonstrated an absence of the α and β El PDHC subunits. After 2 y of treatment with 500 mg/d thiamine, the patient was clinically improved. A genetic study of the main regions of mutations (exon 10 and 11) in the X chromosome encoding for the El α subunit of PDHC did not show any mutation. These data indicate that, although genetically different, this case enters in a very rare category of patients with PDHC deficiency without cerebral dysfunction and improved by thiamine + L-carnitine therapy.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonne, G., Benelli, C., Meirleir, L. et al. El Pyruvate Dehydrogenase Deficiency in a Child with Motor Neuropathy. Pediatr Res 33, 284–288 (1993). https://doi.org/10.1203/00006450-199303000-00016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199303000-00016
This article is cited by
-
Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival
Human Genome Variation (2017)
-
The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders
Journal of Inherited Metabolic Disease (2015)
-
Peripheral neuropathy and inborn errors of metabolism in adults
Journal of Inherited Metabolic Disease (2007)
-
Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency
European Journal of Pediatrics (2006)
-
The treatment of congenital lactic acidoses
Journal of Inherited Metabolic Disease (1996)